148 related articles for article (PubMed ID: 33170148)
1. Targeting LncRNA EPIC1 to inhibit human colon cancer cell progression.
Wu Q; Wei J; Zhao C; Xiang S; Shi M; Wang Y
Aging (Albany NY); 2020 Nov; 15(2):583-594. PubMed ID: 33170148
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA EPIC1 promotes human lung cancer cell growth.
Zhang B; Lu HY; Xia YH; Jiang AG; Lv YX
Biochem Biophys Res Commun; 2018 Sep; 503(3):1342-1348. PubMed ID: 30029875
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA EPIC1 promotes cholangiocarcinoma cell growth.
Li Y; Cai Q; Li W; Feng F; Yang L
Biochem Biophys Res Commun; 2018 Oct; 504(4):654-659. PubMed ID: 30205958
[TBL] [Abstract][Full Text] [Related]
4. LncRNA EPIC1 protects human osteoblasts from dexamethasone-induced cell death.
Zhang XY; Shan HJ; Zhang P; She C; Zhou XZ
Biochem Biophys Res Commun; 2018 Sep; 503(4):2255-2262. PubMed ID: 29959919
[TBL] [Abstract][Full Text] [Related]
5. LncRNA EPIC1 downregulation mediates hydrogen peroxide-induced neuronal cell injury.
Sun J; Zheng J; Li Y; Yan M; Li P; Ma L
Aging (Albany NY); 2019 Dec; 11(23):11463-11473. PubMed ID: 31812951
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA EPIC1 interacts with YAP1 to regulate the cell cycle and promote the growth of pancreatic cancer cells.
Xia P; Liu P; Fu Q; Liu C; Luo Q; Zhang X; Cheng L; Qin T; Zhang H
Biochem Biophys Res Commun; 2020 Feb; 522(4):978-985. PubMed ID: 31810603
[TBL] [Abstract][Full Text] [Related]
7. Long Non-Coding RNA THOR Depletion Inhibits Human Non-Small Cell Lung Cancer Cell Growth.
Jiao PF; Tang PJ; Chu D; Li YM; Xu WH; Ren GF
Front Oncol; 2021; 11():756148. PubMed ID: 34868966
[TBL] [Abstract][Full Text] [Related]
8. MYC-binding lncRNA EPIC1 promotes AKT-mTORC1 signaling and rapamycin resistance in breast and ovarian cancer.
Wang Y; Zhang M; Wang Z; Guo W; Yang D
Mol Carcinog; 2020 Oct; 59(10):1188-1198. PubMed ID: 32810332
[TBL] [Abstract][Full Text] [Related]
9. LncRNA EPIC1 promotes proliferation and inhibits apoptosis of gallbladder cancer cells by interacting with LET.
Fu C; Nie L; Yin T; Xu X; Lu W
Ann Hepatol; 2021 Dec; 26():100563. PubMed ID: 34653690
[TBL] [Abstract][Full Text] [Related]
10. Long Non-coding RNA EPIC1 Promotes Cell Proliferation and Motility and Drug Resistance in Glioma.
Wang J; Yang S; Ji Q; Li Q; Zhou F; Li Y; Yuan F; Liu J; Tian Y; Zhao Y; Zheng Y
Mol Ther Oncolytics; 2020 Jun; 17():130-137. PubMed ID: 32322669
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA EPIC1 inhibits viability and invasion of osteosarcoma cells by promoting MEF2D ubiquitylation.
Zhao W; Zhang D; Qin P; Zhang J; Cui X; Gao J; Wang J; Li J
Int J Biol Macromol; 2019 May; 128():566-573. PubMed ID: 30703420
[TBL] [Abstract][Full Text] [Related]
12. lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer.
Wang Z; Yang B; Zhang M; Guo W; Wu Z; Wang Y; Jia L; Li S; ; Xie W; Yang D
Cancer Cell; 2018 Apr; 33(4):706-720.e9. PubMed ID: 29622465
[TBL] [Abstract][Full Text] [Related]
13. Lnc-MUC20-9 binds to ROCK1 and functions as a tumor suppressor in bladder cancer.
Dai R; Zhou Y; Chen Z; Zou Z; Pan Z; Liu P; Gao X
J Cell Biochem; 2020 Oct; 121(10):4214-4225. PubMed ID: 31898364
[TBL] [Abstract][Full Text] [Related]
14. LncRNA EPIC1 promotes tumor angiogenesis via activating the Ang2/Tie2 axis in non-small cell lung cancer.
Hou Y; Jia H; Cao Y; Zhang S; Zhang X; Wei P; Xie J; Dong W; Wang B
Life Sci; 2021 Feb; 267():118933. PubMed ID: 33359744
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA colon cancer-associated transcript 2 may promote esophageal cancer growth and metastasis by regulating the Wnt signaling pathway.
Wang X; Wang X
Oncol Lett; 2019 Aug; 18(2):1745-1754. PubMed ID: 31423241
[TBL] [Abstract][Full Text] [Related]
16. Novel lncRNA LINC00941 Promotes Proliferation and Invasion of Colon Cancer Through Activation of MYC.
Chang L; Zhou D; Luo S
Onco Targets Ther; 2021; 14():1173-1186. PubMed ID: 33654409
[TBL] [Abstract][Full Text] [Related]
17. Effects of LncRNA Lnc-LIF-AS on cell proliferation, migration and invasion in a human cervical cancer cell line.
Song W; Wang J; Liu H; Zhu C; Xu F; Qian L; Shen Z; Zhu J; Yin S; Qin J; Chen L; Wu D; Nashan B; Shan G; Xiao W; Zhou Y
Cytokine; 2019 Aug; 120():165-175. PubMed ID: 31085454
[TBL] [Abstract][Full Text] [Related]
18. Triptonide inhibits human nasopharyngeal carcinoma cell growth via disrupting Lnc-RNA THOR-IGF2BP1 signaling.
Wang SS; Lv Y; Xu XC; Zuo Y; Song Y; Wu GP; Lu PH; Zhang ZQ; Chen MB
Cancer Lett; 2019 Feb; 443():13-24. PubMed ID: 30503558
[TBL] [Abstract][Full Text] [Related]
19. LncRNA ZFAS1 contributes to osteosarcoma progression via miR-520b and miR-520e-mediated inhibition of RHOC signaling.
Liu X; Wang M; Zhang L; Huang L
Clinics (Sao Paulo); 2023; 78():100143. PubMed ID: 36473367
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of lncRNA IGFBP4-1 reprograms energy metabolism to promote lung cancer progression.
Yang B; Zhang L; Cao Y; Chen S; Cao J; Wu D; Chen J; Xiong H; Pan Z; Qiu F; Chen J; Ling X; Yan M; Huang S; Zhou S; Li T; Yang L; Huang Y; Lu J
Mol Cancer; 2017 Sep; 16(1):154. PubMed ID: 28946875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
